Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02977468 |
|---|---|
| Brief Title: | Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (Pembro/IORT) |
| First Submitted : | November 28, 2016 |
| First Submitted that Met QC Criteria : | November 28, 2016 |
| First Posted : | November 30, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 20, 2023 |
| Last Update Posted : | July 24, 2023 |